MMSI
Merit Medical·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 1
Consensus Rating "Buy"
Ample Liquidity
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About MMSI
Merit Medical Systems, Inc.
A leading global manufacturer and marketer of healthcare technology
Healthcare Equipment and Supplies
--
05/11/1990
NASDAQ Stock Exchange
7,400
12-31
Common stock
1600 West Merit Parkway, South Jordan, Utah 84095
--
Merit Medical Systems, Inc., was founded in July 1987 in Utah. The company is a worldwide developer, manufacturer and marketer of medical devices. These devices are widely used in interventional and diagnostic procedures. The company's mission is to provide physicians and healthcare professionals with innovative, high-quality products that improve patient care and perform safe, efficient procedures. The business is divided into the following markets: Diagnostic and Interventional Cardiology, Interventional Radiology, Interventional Gastroenterology, Interventional Pulmonology, Thoracic Surgery, Nephrology Interventional and Vascular Surgery. The company operates its business through multiple branches at home and abroad. The company designs, develops, manufactures and sells innovative products that provide high-quality, high-value and high-safety products to customers and the patients they serve.
Earnings Call
Company Financials
EPS
MMSI has released its 2025 Q3 earnings. EPS was reported at 0.92, versus the expected 0.83, beating expectations. The chart below visualizes how MMSI has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
MMSI has released its 2025 Q3 earnings report, with revenue of 384.16M, reflecting a YoY change of 13.04%, and net profit of 27.75M, showing a YoY change of -2.42%. The Sankey diagram below clearly presents MMSI's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available



